补充和凝血级联交谈在子宫内膜异位症和Janus激酶抑制剂的潜力-一个网络的元分析
Monika Golinska1,2, Aleksander Rycerz1, Matylda Sobczak1
1Department of Biostatistics and Translational Medicine, Medical University of Lodz, Lodz, Poland.
Frontiers in immunology
|July 23, 2025
概括
子宫内膜异位症涉及免疫失调,补充和凝血通路. 补充C3和JAK抑制剂显示了这种疾病的治疗潜力.
科学领域:
- 生殖生物学 生殖生物学
- 免疫学 免疫学 免疫学
- 基因组学就是基因组学.
背景情况:
- 子宫内膜异位症 (EM) 病原和免疫失调机制尚未完全理解.
- 识别EM损伤形成的关键分子途径和与之相关的转录基因变化在eutopic子宫内膜中至关重要.
研究的目的:
- 为了确定驱动子宫内膜异位病变形成的关键分子通路.
- 为了检测与子宫内膜异位症相关联的eutopic子宫内膜的转录基因变化.
- 探索子宫内膜异位症的潜在治疗点.
主要方法:
- 利用基因表达大巴和ArrayExpress用于转录基因数据.
- 在从有和没有子宫内膜异位症的妇女的样本上进行了差异性基因表达和网络元分析.
- 进行了基因本体学,丰富和药物基因组学分析.
主要成果:
- 在eutopic子宫内膜中确定了差异性基因表达 (例如,CCL21,BIRC3,CEL,LEFTY1).
- 宫外病变显示补体 (C7,C3) 和巨细胞标志物 (CPA3,KIT) 的表达增加.
- 突出补充/凝血,炎症,血管新生和ECM重塑作为关键驱动因素;确定了JAK,CDK和拓酶抑制剂作为潜在的目标.
结论:
- 子宫内膜异位症涉及补充/凝血,巨细胞,ECM重塑和JAK/STAT3信号的相互作用.
- 补充C3和JAK抑制剂是重要的治疗候选者.
- 患有子宫内膜异位症和没有子宫内膜异位症的女性中,eutopic子宫内膜异位症之间的转录组差异可能有助于诊断的发展.
相关概念视频
01:20The JAK-STAT Signaling Pathway
9.3K
Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as SH2...
9.3K
01:19Interactions Between Signaling Pathways
6.5K
Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.5K
01:20Antiplatelet Drugs: Prostaglandin Synthesis, P2Y12 and Glycoprotein IIb/IIIa Inhibitors
648
Antiplatelet drugs emerge as frontline defenders against the insidious threat of thromboembolic diseases, where abnormal clots obstruct vital blood vessels. These drugs stand as bulwarks, inhibiting platelet aggregation and clot formation, thereby mitigating the risk of life-threatening conditions like myocardial infarction, coronary artery disease, and thrombotic strokes.
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
Prostaglandin synthesis inhibitors, exemplified by the widely known aspirin, wield their power by irreversibly acetylating...
648
01:20Extrinsic and Intrinsic Pathways of Hemostasis
9.2K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
9.2K
01:16TGF - β Signaling Pathway
7.7K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.7K
01:22Hormonal Regulation of the Menstrual Cycle
704
The ovarian cycle regulates endometrial changes throughout a single menstrual cycle via the coordinated action of gonadotrophin-releasing hormone (GnRH) and gonadotrophins.
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
At puberty, GnRH begins a pulsatile release pattern, which triggers the anterior pituitary gland to secrete follicle-stimulating hormone (FSH) and luteinizing hormone (LH). The frequency and amplitude of GnRH pulses vary across the menstrual cycle, with faster pulses favoring LH release and slower pulses favoring FSH...
704